ALLMedicine™ Brain Neoplasms Center
Research & Reviews 124 results
https://doi.org/10.1007/s11060-022-04207-0
Journal of Neuro-oncology; Holtzman AL, Glassman GE et. al.
Jan 25th, 2023 - Benign intracranial meningioma is one of the most common primary brain neoplasms. Proton therapy has been increasingly utilized for nonoperative management of this neoplasm, yet few long-term outcomes studies exist. The medical records of a total ...
https://clinicaltrials.gov/ct2/show/NCT02956291
Jan 6th, 2023 - The primary objective of this study is to 1) evaluate the utility of quantitative MRI imaging including 3D-MRF in differentiating among different brain tumors and differentiating recurrent brain tumor (TR) from treatment effects Secondary objectiv...
https://doi.org/10.1007/s00381-022-05764-5
Child's Nervous System : ChNS : Official Journal of the I... Falco J, Broggi M et. al.
Dec 16th, 2022 - Surgical resection represents the mainstay of treatment, in pediatric central nervous system (CNS) tumors, and aggressive resection correlates with prognosis for several histotypes. Sodium fluorescein (SF), a green, water-soluble dye, is used as n...
https://doi.org/10.1016/S0140-6736(22)00839-X
Lancet (London, England); Butterfield JT, Golzarian S et. al.
Dec 13th, 2022 - Disparities in treatment and outcomes disproportionately affect minority ethnic and racial populations in many surgical fields. Although substantial research in racial disparities has focused on outcomes, little is known about how surgeon recommen...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629486
Neuro-oncology Odia Y, Gutierrez AN et. al.
Nov 3rd, 2022 - The mainstays of radiation therapy include external beam radiation therapy (EBRT) and internally implanted radiation, or brachytherapy (BT), all with distinct benefits and risks in terms of local or distant tumor control and normal brain toxicitie...
Clinicaltrials.gov 9 results
https://clinicaltrials.gov/ct2/show/NCT02956291
Jan 6th, 2023 - The primary objective of this study is to 1) evaluate the utility of quantitative MRI imaging including 3D-MRF in differentiating among different brain tumors and differentiating recurrent brain tumor (TR) from treatment effects Secondary objectiv...
https://clinicaltrials.gov/ct2/show/NCT05049148
Sep 1st, 2022 - This is a descriptive study that did not include any intervention other than tumor tissue preservation and blood sampling.
https://clinicaltrials.gov/ct2/show/NCT05293210
Aug 4th, 2022 - The use of corticosteroids in COVID 19 in hospitalized patients with moderate symptoms has not been adequately studied in randomized clinical trials, the studies and clinical trials having focused on critical or severe patients. The few studies av...
https://clinicaltrials.gov/ct2/show/NCT02393131
Jul 19th, 2019 - This is a single institutional, randomized phase II study to assess the neurocognitive outcome of conformal WBRT with or without hippocampal avoidance in patients with multiple brain metastases. Patients will be randomly assigned 1:1 to receive co...
https://clinicaltrials.gov/ct2/show/NCT02212964
Mar 31st, 2016 - Post-treatment radiographic imaging change (PTRIC) is seen in approximately 50% of patients who are treated for brain neoplasms using chemotherapy and radiotherapy. PTRIC can be attributed to true disease progression or a form of benign radiograph...
News 2 results
https://www.staging.medscape.com/viewarticle/906321
Abstract and Introduction Abstract Background: Primary central nervous system lymphoma is a rare, malignant non-Hodgkin lymphoma that can arise in the brain, spinal cord, eye, leptomeninges, or cranial nerves. Primary central nervous system lympho...
https://www.medscape.com/viewarticle/906321
Abstract and Introduction Abstract Background: Primary central nervous system lymphoma is a rare, malignant non-Hodgkin lymphoma that can arise in the brain, spinal cord, eye, leptomeninges, or cranial nerves. Primary central nervous system lympho...